This study is a double-blind, placebo-controlled, randomized trial designed to assess the efficacy and safety of a single dose level of gefapixant in female subjects with moderate to severe IC/BPS. The study will consist of 4 phases: Screening, Baseline, Treatment, and Follow-up.